Attention-Deficit/Hyperactivity Disorder Is the Extreme and Impairing Tail of a Continuum - 18/03/15
Doi : 10.1016/j.jaac.2015.01.014
Philip Asherson, MD ⁎ 
, Maciej Trzaskowski, PhD
, Maciej Trzaskowski, PhD Social Genetic and Developmental Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
∗Correspondence to Philip Asherson, MD, Institute of Psychiatry, SGDP, De Crespigny Park, London, SE5 8AF, United Kingdom
Le texte complet de cet article est disponible en PDF.
| Disclosure: Prof. Asherson has received research support from the UK National Institute of Health Research, the Biomedical Research Centre for Mental Health at King’s College London and the South London and Maudsley National Health Service Foundation Trust, Action Medical Research, and the European Union’s 7th Framework and Horizon 2020. He has served on the speakers’ bureau and advisory board for Janssen-Cilag, Novartis, Shire, and Eli Lilly and Co. He has received unrestricted educational or research awards from Shire, Novartis, Eli Lilly and Co., Janssen, QbTech, Vifor Pharma, GWPharma, and PCM Scientific. All fees related to these activities are paid to Kings College London. Dr. Trzaskowski reports no biomedical financial interest or potential conflicts of interest. |
© 2015
American Academy of Child and Adolescent Psychiatry. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 54 - N° 4
P. 249-250 - avril 2015 Retour au numéro
Article précédent
- Meeting the Intervention Needs of Military Children and Families
- Stephen J. Cozza
- Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in Children
- Michael H. Bloch, Eric A. Storch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?